Skip to main content
Erschienen in: Neurological Sciences 6/2013

01.06.2013 | Original Article

Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years

verfasst von: X. Huang, W. B. Liu, L. N. Men, H. Y. Feng, Y. Li, C. M. Luo, L. Qiu

Erschienen in: Neurological Sciences | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The objectives of the study are to study the clinical features of myasthenia gravis in southern China. A retrospective study was carried out on all patients who were diagnosed with myasthenia gravis at the First Affiliated Hospital of Sun Yat-sen University during 1987–2009. Of the 2,154 myasthenia gravis patients, the gender ratio (male:female) was 1:1.15. The median age at onset was 18 years. There was a single peak distribution of age at onset, and 44.8  % were children (≤14 years) at first onset. 1,766 patients (82.0 %) only had ocular symptoms at onset. 1,451 patients (67.4 %) were classified as Osserman grade I. 250 unselected patients received anti-acetylcholine receptor antibodies test, in which only 51.2 % were positive. Computed tomography scan/magnetic resonance Imaging of chest were done in 1,354 patients, of which 899 patients (66.4 %) had thymic hyperplasia and 201(14.8 %) had thymoma. There were 150 patients (7.0 %) with myasthenia gravis combined with other autoimmune diseases, in which hyperthyroidism was most common (84 %). 189 (8.8 %) patients experienced 267 episodes of crisis. The rate of family myasthenia gravis was 1.6 % (35/2,154). In conclusion, the clinical features and demography of myasthenia gravis patients in this study are significantly different from prior studies on other regions and ethnic groups.
Literatur
1.
Zurück zum Zitat Jaretzki A III, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70 327–324 Jaretzki A III, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70 327–324
2.
Zurück zum Zitat Victor M, Ropper AH (2001) Myasthenia gravis and related disorders of the neuromuscular junction. In: Victor M, Ropper AH (eds) Adams and Victor’s principles of neurology, 7th edn. McGraw-Hill, New York, pp 1536–1539 Victor M, Ropper AH (2001) Myasthenia gravis and related disorders of the neuromuscular junction. In: Victor M, Ropper AH (eds) Adams and Victor’s principles of neurology, 7th edn. McGraw-Hill, New York, pp 1536–1539
3.
Zurück zum Zitat Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Hojer-Pedersen KE, Rasmussen K et al (1998) Mortality and survival in myasthenia gravis: a Danish population based study. Neurol Neurosurg Psychiatry 64:78–83CrossRef Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Hojer-Pedersen KE, Rasmussen K et al (1998) Mortality and survival in myasthenia gravis: a Danish population based study. Neurol Neurosurg Psychiatry 64:78–83CrossRef
4.
Zurück zum Zitat Cui LY, Tang XF, Xu XH (1994) Clinical type, electromyography and AchRab in MG patients. Clin J Neurol 1:65–67 Cui LY, Tang XF, Xu XH (1994) Clinical type, electromyography and AchRab in MG patients. Clin J Neurol 1:65–67
5.
Zurück zum Zitat Stalberg E, Trontelj J (1979) Single fiber electromyography. Mirvalle Press, New York, pp 103–122 Stalberg E, Trontelj J (1979) Single fiber electromyography. Mirvalle Press, New York, pp 103–122
6.
Zurück zum Zitat Kirmani JF, Yahia AM, Qureshi AI (2004) Myasthenic crisis. Curr Treat Options Neurol 6:13–15CrossRef Kirmani JF, Yahia AM, Qureshi AI (2004) Myasthenic crisis. Curr Treat Options Neurol 6:13–15CrossRef
7.
Zurück zum Zitat Xu J, Yang M, Li Baohua et a1 (1999) Myasthenia gravis: clinical study in 2385 patients. Chin J Neurol 32(6):347–350 Xu J, Yang M, Li Baohua et a1 (1999) Myasthenia gravis: clinical study in 2385 patients. Chin J Neurol 32(6):347–350
8.
Zurück zum Zitat Kawaguchi N, Kuwabara S, Nemoto Y et al (2004) Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999–2000. Neurol Sci 224:43–47CrossRef Kawaguchi N, Kuwabara S, Nemoto Y et al (2004) Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999–2000. Neurol Sci 224:43–47CrossRef
9.
Zurück zum Zitat Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. Neurol Neurosurg Psychiatry 71:352–356CrossRef Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. Neurol Neurosurg Psychiatry 71:352–356CrossRef
10.
Zurück zum Zitat Robertson NP, Deans J, Compston DA (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. Neurol Neurosurg Psychiatry 65:492–496CrossRef Robertson NP, Deans J, Compston DA (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. Neurol Neurosurg Psychiatry 65:492–496CrossRef
11.
Zurück zum Zitat Singhal BS, Bhatia NS, Umesh T, Menon S (2008) Myasthenia gravis: a study from India. Neurology India 56(3):352–355 Singhal BS, Bhatia NS, Umesh T, Menon S (2008) Myasthenia gravis: a study from India. Neurology India 56(3):352–355
12.
Zurück zum Zitat Thanvi BR, Lo TC (2004) Update on myasthenia gravis. Postgrad Med 80:690–700CrossRef Thanvi BR, Lo TC (2004) Update on myasthenia gravis. Postgrad Med 80:690–700CrossRef
13.
Zurück zum Zitat Lok Wing, Das Asha, Helen TL (2003) Myasthenia gravis in Singapore. Neuro J Southeast Asia 8:35–40 Lok Wing, Das Asha, Helen TL (2003) Myasthenia gravis in Singapore. Neuro J Southeast Asia 8:35–40
14.
Zurück zum Zitat Yu YL, Hawkins BR, Ip MS, Wong V, Woo E (1992) Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 86:113–119PubMedCrossRef Yu YL, Hawkins BR, Ip MS, Wong V, Woo E (1992) Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 86:113–119PubMedCrossRef
15.
Zurück zum Zitat Guidetti D, Sabadini R, Bondavalli M, Cavalletti S, Lodesani M, Mantegazza R et al (1998) Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 14:381–387PubMedCrossRef Guidetti D, Sabadini R, Bondavalli M, Cavalletti S, Lodesani M, Mantegazza R et al (1998) Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 14:381–387PubMedCrossRef
16.
Zurück zum Zitat Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R (2007) Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. Neurol Neurosurg Psychiatry 78:1109–1112CrossRef Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R (2007) Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. Neurol Neurosurg Psychiatry 78:1109–1112CrossRef
17.
Zurück zum Zitat Vaideeswar P, Padmanabhan A, Deshpande JR, Pandit SP (2004) Thymoma: a pathological study of 50 cases. Postgrad Med 50:94–99 Vaideeswar P, Padmanabhan A, Deshpande JR, Pandit SP (2004) Thymoma: a pathological study of 50 cases. Postgrad Med 50:94–99
18.
Zurück zum Zitat Roy A, Kalita J, Misra UK, Kar D, Agarwal A, Misra SK (2000) A study of myasthenia gravis in patients with and without thymoma. Neurol India 48:343–346PubMed Roy A, Kalita J, Misra UK, Kar D, Agarwal A, Misra SK (2000) A study of myasthenia gravis in patients with and without thymoma. Neurol India 48:343–346PubMed
19.
Zurück zum Zitat Alexiev BA, Drachenberg CB, Burke AP (2007) Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagn Pathol 2:13PubMedCrossRef Alexiev BA, Drachenberg CB, Burke AP (2007) Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagn Pathol 2:13PubMedCrossRef
20.
Zurück zum Zitat Yaman A, Yaman H (2003) Ocular myasthenia gravis coincident with thyroid ophthalmopathy. Neurol India 51:100–101PubMed Yaman A, Yaman H (2003) Ocular myasthenia gravis coincident with thyroid ophthalmopathy. Neurol India 51:100–101PubMed
21.
Zurück zum Zitat Thomas CE, Mayer SA, Gungor Y et al (1997) Myasthenic crisis: clinical features, mortality complications and risk factors for prolonged intubation. Neurology 48:1253–1260PubMedCrossRef Thomas CE, Mayer SA, Gungor Y et al (1997) Myasthenic crisis: clinical features, mortality complications and risk factors for prolonged intubation. Neurology 48:1253–1260PubMedCrossRef
22.
Zurück zum Zitat Tao B, Mingshan Y, Jinzhi X et al (1999) Clinical features and genetic study of the familial myasthenia gravis. Chin J Neuroimmunol Neurol 6:87–91 Tao B, Mingshan Y, Jinzhi X et al (1999) Clinical features and genetic study of the familial myasthenia gravis. Chin J Neuroimmunol Neurol 6:87–91
23.
Zurück zum Zitat Hai-ping W, Shu-hui W, Zhi-qia C (2005) Clinical features and genetic susceptibility of the familial myasthenia gravis. Chin J Neurol 38:510–512 Hai-ping W, Shu-hui W, Zhi-qia C (2005) Clinical features and genetic susceptibility of the familial myasthenia gravis. Chin J Neurol 38:510–512
Metadaten
Titel
Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years
verfasst von
X. Huang
W. B. Liu
L. N. Men
H. Y. Feng
Y. Li
C. M. Luo
L. Qiu
Publikationsdatum
01.06.2013
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 6/2013
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1157-z

Weitere Artikel der Ausgabe 6/2013

Neurological Sciences 6/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.